A Preclinical, Precision Medicine Approach Based on Retargeted Herpesviruses with Oncoimmunotherapeutic Potential (PreMeRetHOn)

Scientific director: prof. Gianni Tatiana

Funding body: MUR

Duration: 16/10/2023 - 15/10/2025